Clinical and molecular evaluation of MEFV gene variants in the Turkish population: a study by the National Genetics Consortium

Dundar M., Fahrioglu U., Yildiz S. H., Bakir-Gungor B., Temel S. G., Akin H., ...Daha Fazla

FUNCTIONAL & INTEGRATIVE GENOMICS, cilt.22, sa.3, ss.291-315, 2022 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 22 Sayı: 3
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1007/s10142-021-00819-3
  • Dergi Adı: FUNCTIONAL & INTEGRATIVE GENOMICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, Chemical Abstracts Core, EMBASE, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.291-315
  • Anahtar Kelimeler: Familial Mediterranean fever, Genotype-phenotype correlations, MEFV, National Genetics Consortium, FAMILIAL MEDITERRANEAN FEVER, PROTEIN ASC, KAPPA-B, MUTATIONS, PYRIN, AUTOINFLAMMATION, ASSOCIATIONS, AMYLOIDOSIS, PREVALENCE, ACTIVATION
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Familial Mediterranean fever (FMF) is a monogenic autoinflammatory disorder with recurrent fever, abdominal pain, serositis, articular manifestations, erysipelas-like erythema, and renal complications as its main features. Caused by the mutations in the MEditerranean FeVer (MEFV) gene, it mainly affects people of Mediterranean descent with a higher incidence in the Turkish, Jewish, Arabic, and Armenian populations. As our understanding of FMF improves, it becomes clearer that we are facing with a more complex picture of FMF with respect to its pathogenesis, penetrance, variant type (gain-of-function vs. loss-of-function), and inheritance. In this study, MEFV gene analysis results and clinical findings of 27,504 patients from 35 universities and institutions in Turkey and Northern Cyprus are combined in an effort to provide a better insight into the genotype-phenotype correlation and how a specific variant contributes to certain clinical findings in FMF patients. Our results may help better understand this complex disease and how the genotype may sometimes contribute to phenotype. Unlike many studies in the literature, our study investigated a broader symptomatic spectrum and the relationship between the genotype and phenotype data. In this sense, we aimed to guide all clinicians and academicians who work in this field to better establish a comprehensive data set for the patients. One of the biggest messages of our study is that lack of uniformity in some clinical and demographic data of participants may become an obstacle in approaching FMF patients and understanding this complex disease.